Comparison Chart Summit Therapeutics Inc.

Stocks

SMMT

US86627T1088

Biotechnology & Medical Research

Real-time Estimate Cboe BZX Other stock markets 20:00:00 2026-07-02 EDT			5-day change	1st Jan Change
22.18 ^USD	+43.81%		+8.74%	-11.84%

06-22	Analyst recommendations: Accenture, Conocophillips, Diamondback Energy, Oracle, Applied Materials…
06-12	Summit Therapeutics Insider Bought Shares Worth $49,987,200, According to a Recent SEC Filing	MT

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Compared values

		Sector	Change	5-day change	YTD change	1-year change	5-year change	Capi.	ST	MT	LT
	SUMMIT THERAPEUTICS INC.	Bio Therapeutic Drugs	+7.23%	+8.74%	-11.84%	-31.83%	+98.97%	11.97B